Effect of glucagon-like peptide-1 receptor agonists on renal function: a meta-analysis of randomized controlled trials
Taurus's own product page states these therapies are not FDA-approved for the treatment, cure, or prevention of any disease, and the telehealth consent form patients sign states directly that the FDA does not approve or review compounded products for safety, effectiveness, or quality before they're marketed
For context, the vast majority of the brands claimed 250-500 mg, with two exceptions: Fresh Nutrition, which claimed 167mg, and Emily Bright Formula, which claimed only 2mg
Bone Miner
Addressing these barriers are essential before such systems can be routinely implemented for comprehensive evaluation and translation
GLP-1 receptor: a new target for sepsis